Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Rheumatoid Arthritis
Related studies linked through entity extraction aliases.
A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)
- Status
- COMPLETED
- Phase
- N/A
CAMEO: Canadian Methotrexate and Etanercept Outcome Study
- Status
- COMPLETED
- Phase
- PHASE4
Reciprocating Medical Devices - a Study of a New Safety Device
- Status
- COMPLETED
- Phase
- NA
A Study of ARRY-438162 in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
A Long-term Moderate Intervention With n-3 LC-PUFA-supplemented Dairy Products in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- NA
Assessment of the Effectiveness of Low-Level Laser Therapy on the Hands of Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- NA
Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2